ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

DCE Makes Changes In Procedure For Occupational Studies

November 21, 1986

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Toxicology Program Board To Review Nine Substances.

January 14, 2000

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

In Brief: NCI To Leave Blair, Landlow Building; House To Hold Hearings March 5 On NCI’s 1998 Budget

February 13, 1987

New Model Provides Better Estimate of Breast Cancer Risk in Black Women.

November 30, 2007